Lactation Elevated 1 (LACE1) (C-Term) Peptide
Quick Overview for Lactation Elevated 1 (LACE1) (C-Term) Peptide (ABIN1541827)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- MDDLGLSQDS AEGLSMFTGE EEIFAFQRTI SRLTEMQTEQ YWNEGDRTKK
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-LACE1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- LACE1 (Lactation Elevated 1 (LACE1))
-
Background
-
This gene encodes a protein with possible ATPase function. The protein contains a P-loop motif and a five-domain structure that is conserved in fly, yeast, and bacteria. Two conserved estrogen receptor binding sites are located within 2.5 kb of this gene.
Alias Symbols: AFG1
Protein Size: 481 -
Molecular Weight
- 53 kDa
-
Gene ID
- 246269
-
NCBI Accession
- NM_145315, NP_660358
-
UniProt
- Q8WV93
Target
-